Joseph Del Preto
Analyst · Canaccord
Thanks, Ryan. I'll now walk you through our third quarter results in detail before moving on to guidance for the fourth quarter and full year 2022. We're pleased to deliver durable growth, positive free cash flow for the seventh consecutive quarter to raise our expectations for the year, underscoring the mission criticality of organic social media management. Revenue for the third quarter was $65.3 million, representing 32% year-over-year growth. ARR exiting Q3 was $271.3 million, up 33% year-over-year. With the global business environment showing strain, we did see slower Q3 customer activity for both new business and expansion with our lowest touch, least sophisticated customers. Our mid-market and enterprise segments continue to outperform our expectations and are powering a disproportionate amount of our net new ARR. Driven by healthy momentum in our enterprise business, our ramping partnerships and previously unanticipated pricing changes, we expect to have a record net new ARR in Q4. We had 638 net new customers in Q3 to finish the quarter with 34,258 customers, up 12% year-over-year. The number of customers continue more than $10,000 in ARR reached 6,111 up 40% from a year ago. The number of customers could train more than $50,000 in ARR reached $843 up 76% from a year ago and our strongest ever 500,000 net addition quarter outside of a Q4. Q3 ACV growth of 9% year-over-year was again driven primarily by larger initial deal sizes. In discussing the remainder of the income statement, please note that unless otherwise stated, all references to our expenses, operating results and share count on a non-GAAP basis to exclude stock-based compensation expense, and are reconciled to our GAAP results in the earnings press release that was just issued before this call. In Q3, gross profit was $50.7 million, representing a gross margin of 77.6%. This is up 220 basis points compared to gross margin of 75.4% a year ago and again represents our highest gross margin in 5 years. Sales and marketing expenses for Q3 were $26.2 million or 40% of revenue, up from 39% a year ago. We're fortunate to hire well throughout the quarter and continue to make meaningful investments in our future. Research and development expenses for Q3 were $13.2 million or 20% of revenue, up from 90% a year ago. Headcount and absolute expense growth continues to match the trajectory of transformative R&D investments. General and administrative expenses for Q3 were $12.7 million or 90% of revenue, down from 21% a year ago. We have normalized our G&A spending and expect to deliver consistent leverage as a percent of revenue going forward. Non-GAAP operating expense loss for Q3 was $1.4 million for a negative 2.2% operating margin. We are pleased with the ongoing efficiency improvements as we scale and we exceed our expectations this quarter due to revenue outperformance. Non-GAAP net loss for Q3 was $1.0 million for a net loss of $0.02 per share based on 54.7 million weighted average shares of common stock outstanding compared to a net loss of $1.8 million and $0.03 per share a year ago. Turning to the balance sheet and cash flow statement. We ended Q3 with $181.9 million in cash, cash equivalents and marketable securities, up from $181.7 million at the end of Q2. Deferred revenue at the end of the quarter was $85.0 million, a strong sequential increase. We continue to progress nicely to our high water mark anticipated in Q4. Looking at both our billed and unbilled contracts, our remaining performance obligations, or RPO, totaled approximately $136.9 million, up from $127.6 million exiting Q2 and up 57% year-over-year. We expect to recognize approximately 81% or $110.3 million of total RPO revenue over the next 12 months. Operating cash flow in Q3 was $1.0 million compared to $4.4 million a year ago. Free cash flow was positive $0.5 million for a positive 1% free cash flow margin ahead of our expectations. Shifting to formal guidance. For the fourth quarter of fiscal 2022, we expect revenue in the range of $69.8 million to $69.9 million while a growth rate of 31%. We expect non-GAAP operating loss in the range of $1.0 million to $0.9 million. This represents an anticipated operating margin of negative 1%. We expect a non-GAAP net loss per share of roughly $0.02 assuming approximately 54.8 million weighted average basic shares of common stock outstanding. For the full year fiscal 2022, we now expect total revenue in the range of $254.0 million to $254.1 million. This is an expected overall reported growth rate of greater than 35%. We're pleased to have our third consecutive quarter increase to 2022 annual guidance. For 2022, we expect non-GAAP operating loss in the range of $5.5 million to $5.4 million. Sprout has annual non-GAAP operating margin expansion of roughly 130 basis points up from our prior margin expansion range of 110 basis points to 120 basis points. We're pleased to forecast faster revenue growth with improved efficiency even as we continue to make growth investments for our future. We expect a non-GAAP net loss per share of roughly $0.10, assuming approximately 54.6 million weighted average basic shares of common stock outstanding. Shifting to the financial considerations for the focus we've outlined today. As Justyn and Ryan have discussed, we've tightened our strategic focus around the healthiest customers in our market. We believe this path will unleash our full growth potential. While we're early, I do want to lay out a framework for how we are thinking about this focus. Our lowest tier standard plan has been increased in price by more than 2x, and we've shifted pricing higher across our plans as we begin to appropriately monetize the value we deliver to our customers. They've also begun to implement price increases on existing customers for the first time. In the immediate term, we expect these changes to drive an acceleration in the rate of ACV growth. In the intermediate term, we expect these changes to drive a step function change in ACV growth. In the long term, we expect continued durable ACV growth as the market matures into our sweet spot. Aligning to much higher ACVs and a more sophisticated customer base, we also expect to work towards world-class NDR at or above 120% on a multiyear basis. We're also shortly improving our unit economics. This strategy may price out those customers that are not right yet to invest in Sprout will result in a smaller number of net new customer additions each quarter. By keeping prices low to cater to the low end of our market, we've been anchoring our growth everywhere else, especially where our customer value proposition increases exponentially and demand is more in elastic. We expect the impact on margins will be net positive, will not be shy about investing in new sales capacity behind strong enterprise demand signals. All else being equal, we expect to see improvement in our rule 40 calculation through a combination of faster revenue growth and/or stronger margins. In summary, our Q3 financial performance highlights the underlying resiliency of our business model, driven by a very strong enterprise new business ramping contribution from our Salesforce partnership and a powerful pricing evolution, we expect the momentum to strengthen through Q4. As we look forward, we remain confident in our ability to outperform our medium-term goals to deliver greater than 30% annual revenue growth and 100 to 300 basis points of annual operating margin improvement. Even against the backdrop of this business environment, we believe we are positioned to pull away and define category leadership in the $100 billion market opportunity ahead. With that, Justyn, Ryan and I are happy to take any of your questions. Operator?